Thalidomide in toxic epidermal necrolysis
- 23 January 1999
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 353 (9149) , 324
- https://doi.org/10.1016/s0140-6736(05)74905-9
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysisThe Lancet, 1998
- Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ SubsetThe Journal of Experimental Medicine, 1998
- The Metabolic and Immunologic Effects of Short-Term Thalidomide Treatment of Patients Infected with the Human Immunodeficiency VirusAIDS Research and Human Retroviruses, 1997
- Thalidomide as an Anti-TNF-α Inhibitor: Implications for Clinical UseClinical Immunology and Immunopathology, 1996